ADVB - CIK 0001941029
The table below shows Advanced Biomed Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $243.23K | $186.33K | $235.99K | $219.97K | $212.40K | $181.70K |
| SG&A |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $276.61K |
| $210.31K |
| $287.92K |
| $347.54K |
| $67.67K |
| $338.32K |
| Operating income | - | - | - | - | - | - |
| Income tax | - | - | - | - | - | - |
| Net income | -$488.94K | $6.86M | -$386.90K | -$1.38M | -$907.90K | -$265.58K |
| EPS (diluted) | -$0.38 | $0.31 | -$0.02 | -$1.35 | -$0.05 | -$0.01 |